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Diet therapy for adults with refractory epi-
lepsy -a review of the evidence 
 
Melissa Bartley 
Westmead Hospital, Sydney, New South 
Wales, Australia 
DOI: 10.21307/ajon-2017-012a 
 
Epilepsy is a chronic neurological condition 
that effects 0.5% -1% of the world’s popula-
tion (WHO 2009). Epilepsy is described as a 
syndrome of recurrent unprovoked seizures, 
which is not limited to one disease but a 
group of disorders (WHO 2009).  
 
Refractory epilepsy is described as a failure 
to control seizures despite adequate use and 
trial of 2 antiepileptic drugs (AED’s) (Kwan et 
al. 2010). Epilepsy that is not controlled by 
AED’s is reported to occur in approximately 
30% of people newly diagnosed with epilep-
sy, and the percentage of people likely to 
become seizure free with multiple trials of 
AED is less than 20% (Luders 2008). People 
with epilepsy experience significant negative 
impacts on there social, cognitive and physi-
cal functioning that contributes to reduced 
quality of life (QoL) and increased mortality 
when compared to the general population 
(Mohammed et al. 2012). 
 
Diet Therapy involves the modification of the 
ratios of carbohydrate, fats and proteins in a 
person diet to induce ketosis. The build up of 
ketones with in the bloods is believed to im-
pact the onset, propagation and cessation of 
seizure activity in the brain (Kossoff et al. 
2011). The exact mechanism is unknown but 
the use of diet therapy for treatment of epi-
lepsy in children has shown to be efficacious.  
 
Diet therapy in adults with refractory focal 
epilepsy is an alternative therapeutic option 
often not considered. The purpose of this 
review is to discuss what the current evi-
dence base for the use of diet therapies in 
adults with refractory epilepsy. 
 
 
Getting the stockings right! Improving 
evidence based practice for neurosurgical 
patients 
 
Kerry-Anne Hegarty, Joanne McLoughlin 
Wollongong Hospital, New South Wales, 
Australia 
DOI: 10.21307/ajon-2017-012b 
 
Venous Thromboembolism (VTE) is one of 
the most common complications following a 
surgical procedure and its prevention and 
management is an important aspect of care 
particularly in those patients who are classed 
as high-risk patients (Assareh, et al, 2014). 
On behalf of the Executive of the Australasian Neuroscience Nurses’ Association (ANNA) it was 
my pleasure to welcome the delegates, presenters and sponsors to the 2018 ANNA Annual Con-
ference at the Sheraton Mirage Resort on the Gold Coast.  
 
The Annual Conference provides an opportunity to promote the exchange of scientific ideas and 
knowledge, and to strengthen relationships with colleagues. We were once again joined together 
with the Neurosurgical Society of Australasia to share some of their scientific sessions, including 
the Eccles Lecture delivered by Professor Neville Knuckey and the Jamieson Memorial Oration 
delivered by Professor Anil Nanda. Our invited speakers included Dr Ruth Mitchell, Nobel Prize 
Winner 2017, neurosurgeon Dr Peter Lucas and Ms Sharon Bale, headache specialist nurse.  
 
Abstract submissions received were of a high quality and provided a very engaging scientific pro-
gram for delegates to experience.  
 
We would like to extend our sincere appreciation to our sponsors, Novartis and Pfizer. We hope 
you enjoyed to the 2018 Annual Conference and look forward to seeing you in Wellington New 
Zealand in 2019.  
 
With kind regards 
Jeanne Barr 
President 
Australasian Neuroscience Nurses’ Association       
DOI: 10.21307/ajon-2017-012 
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Neurosurgical patients are at a high risk of 
developing (VTE) for various reasons includ-
ing; long duration of surgery, long immobiliza-
tion times post-surgery and possible neuro-
logical deficits from complications, which can 
influence mobility (Lukassen et al., 2014). 
VTE prophylactic reduces the risk of DVT 
and Pulmonary Embolism (PE) by about 50 
percent (Mitchell et al., 2015). Collins et al. 
(2015) discusses that adherence to the VTE 
prevention guidelines are not embedded into 
routine clinical practice internationally or in 
Australia. 
 
The aim of this study is to determine; (i) the 
current practice of Neurosurgical nurses in 
regard to VTE prophylaxis (GCS – Graduated 
Compression Stockings) in this patient group; 
(ii) what improvements are required from the 
identified issues/concerns to optimize clinical 
practice and (iii) how may such improve-
ments reduce the incidence of potential VTE 
events. 
 
This study will be an exploratory and obser-
vation study using a mixed methods ap-
proach combining quantitative and qualitative 
research processes using a survey (patients 
and staff), focus groups and audit tool. The 
analysed results (audit and surveys) will be 
fed back to nursing staff at focus groups with 
the aim to explore the enablers and barriers 
to policy compliance and evidenced based 
nursing practices around GCS management.  
 
The results will be further explored and pre-
sented at future focus groups with the aim of 
developing quality improvement projects. The 
study has ethics approval and is currently 
being conducted on the neuroscience ward 
and unit at a major teaching hospital in NSW.  
 
 
Medulloblastoma: a complicated story 
with new technology and hope as the 
game changers 
 
Sharryn Byers 
Nepean Hospital, Sydney, New South Wales, 
Australia 
DOI: 10.21307/ajon-2017-012c 
 
Medulloblastoma is an uncommon tumour in 
adults with incidence rates of 0.6-1 per mil-
lion or approximately 1% of all cranio-spinal 
tumour presentations. In this case study we 
follow the complicated journey of a man and 
his family from diagnosis, treatment and re-
habilitation to discharge.  
 
During his journey the patient, his family and 
the healthcare team faced many challenges 
including rare cranial radiotherapy side ef-
fects, CSF infection, ventriculoperitoneal 
shunt malfunction and social impacts. Finally 
a B-Braun sensor reservoir with ProGav 2.0 
set at 0mmHg with ProSa set at 2 mm Hg 
was implanted, the first time in Australia.  
 
The presentation will focus on this new tech-
nology and explore the theme of hope in long 
term critically ill neurosurgical patients as for 
this man and his family these made a differ-
ence.  
 
 
G-forces, the brain and Newton’s Law 
 
Vicki Evans 
Royal North Shore Hospital, Sydney, New 
South Wales, Australia 
DOI: 10.21307/ajon-2017-012d 
 
The thrill to go fast and push boundaries is 
something that many seek. From John 
Stapp’s rocket sled at Edwards Air Force 
Base in the late 1950’s to todays’ Formula 1 
drivers, the “need for speed” is broadcast 
across TV screens weekly. So too are the 
horror stories of crashes, many at over 
300km/hr. How does the brain stand up to 
speed and G-forces? Are Newton’s Laws 
current today? 
 
There has been much attention in the general 
press on the possibility that high G-force 
roller-coasters are inducing brain injury in 
riders. However, research today does not 
wholeheartedly support this, rather the risk of 
brain injury from a roller-coaster is not in the 
rides, but in the rider – caused by previously 
undetected brain conditions. That said, there 
is some truth that high G-forces do affect the 
brain at a chemical and structural level. 
 
This talk will discuss the mechanism of head 
injury at speed and generally what Newton’s 
Law means in a neurological setting in to-
days’ world. Formula 1 racing and roller 
coaster rides will be evaluated within a neu-
roscience context. 
 
Keywords: Concussion, head injury, New-
ton’s Law, Formula 1, roller-coasters. 
 
 
Evaluation of Parkinson’s disease pass-
port booklet 
 
David Tsui 
Westmead Hospital, Sydney, New South 
Wales, Australia 
DOI: 10.21307/ajon-2017-012e 
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Parkinson’s disease (PD) is a complex and 
multifaceted disease. Studies have shown 
that people with Parkinson’s (PWP) who are 
hospitalised are more likely to develop 
comorbidities such as delirium, urinary tract 
infections, reduced mobility, increased risks 
of falls, medication errors, worsening of Park-
inson’s symptoms and subsequently experi-
ence an increased length of hospital stay.  
 
The PD passport is a brief but comprehen-
sive resource booklet designed to assist the 
care of the person with Parkinson’s disease 
(PWP) from a medical, nursing and carer/
patient’s own perspective. The passport in-
cludes details of Parkinsonian symptoms, 
medication regimen and other aspects of 
care that is specific to the PWP.  
 
Aim: The aim of the study is to determine the 
impact of a personalised Parkinson’s disease 
passport on the care and management of a 
PWP admitted to an Australian hospital. 
 
Method: This is a qualitative pilot study in-
volving two cohorts of 10 patients in each 
arm. One cohort of 10 patients with PD ad-
mitted to hospital will be studied without the 
provision of the PD Passport and a second 
cohort will be studied with the PD Passport 
provided. Separate qualitative questionnaires 
was provided to the patient/carer, doctors 
and nurses to measure their experience in 
caring for the PWP during their admission. 
 
Results: No statistical significance was elicit-
ed in patients’ doctors’ and nurses’ experi-
ence. Patient experience was the closest to 
achieving statistical significance out of the 
three groups. Cognitive impairment also de-
tected in 85% of the subjects. 
 
Conclusion: Contrary to expected outcomes, 
the results of this study suggest that the use 
of a Parkinson’s passport does not signifi-
cantly impact the patient’s care when admit-
ted to hospital. Further prospective study with 
a larger  
 
 
The brain on fire  -  anti-NMDAR encepha-
litis 
 
Grissel Castro 
Toronto Western Hospital-University Health 
Network, Ontario, Canada 
DOI: 10.21307/ajon-2017-012f 
 
Anti-NMDA receptor encephalitis is a rare 
disease that occurs when antibodies pro-
duced by the body’s own immune system 
attack the N-methyld- aspartate receptors 
(NMDAR) in the brain (Anti-NMDA Receptor 
Encephalitis Foundation, 2018).  
 
For a relatively rare condition, Toronto West-
ern Hospital (TWH) noted a staggering four 
cases of anti-NMDA receptor encephalitis in 
2016 alone.  
 
Patients develop a multistage condition that 
progresses from psychosis, memory deficits, 
seizures, respiratory difficulties, abnormal 
catatonic movements and language disinte-
gration into a state of unresponsiveness 
(Dalmau, Lancaster, Hernandez, Rosenfeld 
and Gordon, 2011).  
 
This case study will focus on the pathologies 
and medical journeys of three female patients 
diagnosed with anti-Nmethyl- d-aspartate 
receptor encephalitis at TWH.  
 
This presentation will discuss the unique 
presentations of each of the cases and the 
individualized nursing care plans developed 
to address the unique needs of this patient 
population.  
 
More specifically, it will highlight the im-
portance of ensuring patient and staff safety 
in the development of these cares plans. It 
will also discuss the need for implementing 
ongoing evaluations of these nursing care 
plans to address the developing needs of 
patients as they proceed through the diverse 
and complex phases of the condition. 
 
 
Building evidence to support best prac-
tice specialist nursing services for people 
with Parkinson’s disease in regional com-
munities: an integrative literature review 
 
Associate Professor Marguerite Bramble, 
Associate Professor Rachel Rossiter 
Charles Sturt University, New South Wales, 
Australia 
DOI: 10.21307/ajon-2017-012g 
 
Background: Parkinson’s disease is a chron-
ic, neurodegenerative, incurable, complex 
and disabling neurological condition. In Aus-
tralia and worldwide, the prevalence of Park-
inson’s compared to other neurological condi-
tions is exceeded only by dementia.  
 
The median time from onset to death is 12.2 
years, and in Australia, an estimated 89% 
live most of those years at home, with the 
remaining 11% living in residential facilities. 
As our population ages prevalence is in-
creasing and is higher in rural and remote 
areas. Disease progression is a major driver 
of costs and carer burden due to increasing 
dysfunction in motor and cognitive capacity, 
leading to increasing risk of hospital and resi-
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dential care admission and a need for spe-
cialist services. Integrated, specialist nursing 
care is largely absent in regional communi-
ties, leading to lower health related quality of 
life and poorer management of the condition 
compared to urban areas. 
 
Method: A four-stage integrative framework 
guided the literature review undertaken to 
identify evidence-based models of care spe-
cifically focused on the role of the community 
based specialist neurological nurse caring for 
people with Parkinson’s.  
 
Results: Fourteen models of specialist nurs-
ing care from five countries are included. 
Best practice outcomes focused on improving 
quality of life through nurse-led clinics, early 
intervention strategies, specialist neurological 
assessment, technological advances such as 
telemedicine, multidisciplinary and interdisci-
plinary collaboration, support for family and 
carers and greater in-reach into acute facili-
ties.  
 
Conclusions: Specialist primary nursing ser-
vices that maximise the scope of the nursing 
role, are multidisciplinary and use the latest 
technological advances are more likely to be 
sustainable and cost effective for service pro-
viders and people with Parkinson’s in region-
al communities.  
 
 
Mood screening in acute stroke 
 
Sheila Jala, Martin Good , Aneeta Lal, 
Phillp Zingwe 
Royal North Shore Hospital, Sydney, New 
South Wales, Australia 
DOI: 10.21307/ajon-2017-012h 
 
Background: Post stroke depression (PSD) is 
prevalent in approximately in one third of all 
stroke survivors. It is associated with in-
creased length of stay, poor functional out-
come, higher risk of recurrent strokes and 
increased risk of mortality.  
 
In 50% - 80% of cases, PSD is often unde-
tectable and undertreated. It is important in 
the care of stroke patients to assess their 
mood for early detection and intervention 
management of depression. The clinical 
guidelines for stroke recommends all patients 
be screened for depression using a validated 
tool. However our current practise does not 
routinely screen stroke patients for depres-
sion. This has inspired our nursing team to to 
develop a mood screening protocol as part of 
the acute stroke care for early detection and 
management of depression.  
 
 
Method: Senior acute stroke unit nurses de-
veloped a mood screening protocol that will 
be administered by nurses for stroke pa-
tients. We reviewed several screening tools 
along with consultation with a Neuropsychia-
trist, the Patient Health Questionnaire 2 
(PHQ 2) and Patient Health Questionnaire 9 
(PHQ 9) were chosen because they are rela-
tively easy to use, requires very little time to 
administer and involves minimal training. The 
Speech Pathologist was consulted to modify 
the tools for stroke patients with aphasia. 
 
Results: The mood screening protocol was 
trialled for 3 months. The use of the PHQ 2 
and PHQ 9, including the modified version for 
aphasia were easy to use and able to incor-
porated in patient assessments. In summary, 
26% of the ASU admissions were referred for 
formal assessment of depression post stroke. 
 
Conclusion: Following review of the mood 
screening protocol in the ASU, it is now inte-
grated into the nursing care plans and is also 
been added to the electronic patient stroke 
assessment forms.  
 
 
Journey of a novice research team 
 
Kim Foxall, Catherine Hardman, Katherine 
Schaffarczyk, Diane Lear, Summer Byrne 
and Annie Black 
Westmead Hospital, Sydney, New South 
Wales, Australia 
DOI: 10.21307/ajon-2017-012i 
 
Background: Current pain management strat-
egies for post-operative craniotomy patients 
are limited due to concerns about the effect 
of stronger analgesic agents on level of con-
sciousness and respiratory status. There was 
an opportunity for practice change to opti-
mise the care & experience of patients under-
going elective craniotomy. Intravenous pa-
tient controlled analgesia (PCA) fentanyl was 
introduced for this patient cohort. 
 
Aim: The aim of this presentation is to pro-
vide an overview of the journey taken by the 
research team from inception to commence-
ment of the study. 
 
Methods: Extensive consultation was under-
taken with key stakeholders during the plan-
ning phase. A number of challenges were 
experienced which required a tenacious, de-
termined & cohesive approach from the re-
search team. These challenges included 
gaining support from Neurosurgeons, allocat-
ing time to do the research whilst balancing 
clinical & administrative roles & having little 
funding.  
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This mixed methods study saw patients in the 
treatment group interviewed 3 times during 
their patient journey & administered question-
naires; patients in the non-PCA group were 
interviewed once. Recruitment & patient 
tracking therefore required an organised, sys-
tematic approach; this approach also applied 
to the extensive review of patient medical 
records. 
 
Thematic & narrative analysis of the qualita-
tive data was chosen with team members 
contributing to the analysis of each transcript. 
The potential impact of reflexivity during this 
analysis phase was acknowledged given the 
neurosurgical nursing background of each 
researcher.  
 
Preliminary results indicate that the use of 
PCA fentanyl in this patient cohort is safe 
with patient satisfaction noted. 
 
 
Conclusions: This research study required a 
coordinated team approach. The benefits to 
patient care are rewarding for the effort & 
time expended.  
 
 
Purposeful collaboration - enriching lives 
for people with Parkinson’s disease 
 
Vincent Carroll 
Mid North Coast Local Health District, New 
South Wales, Australia 
DOI: 10.21307/ajon-2017-012j 
 
Patients with Parkinson’s disease have more 
admissions, longer admissions, more compli-
cations and worse outcomes compared to 
similar patients without PD.  
 
Aims: For patients with Parkinson’s Disease 
>75%: Identified <4 hours of admission; Re-
ceive on-time medications;  Carer satisfaction 
with medication management.  
 
Method:  Emergency Department patient 
tracking board icon; Earlier referral to Phar-
macists; contraindicated medications avoid-
ed;  Medications administered on-time; Pro-
cess developed alternatives to oral route for 
medication administration; Clinical guideline 
for care of patients admitted to hospital. 
 
Results: 19% increase medications on-time; 
89% reduction in contraindicated medication 
prescriptions;  Reduced length of stay in hos-
pital.  80% patients or carers were very satis-
fied with their medication management. 
 
 
Conclusion: Patient safety increased along 
with the experience of patients and carers. 
The care experience and clinical staff are 
more satisfied. Aims met.  
 
 
Functional neurological disorders nursing 
management 
 
Vincent Cheah 
Mater Centre for Neurosciences, Brisbane,  
Queensland, Australia 
DOI: 10.21307/ajon-2017-012k 
 
Functional neurological disorders (FND) com-
prise of somatic symptoms such as black-
outs, paralysis, abnormal movements and 
weaknesses that suggest the presence of an 
underlying neurological condition however 
none of the symptoms are explained by dis-
ease. FND is caused by a complex combina-
tion of biological, psychological and social 
factors on the brain (Hallet, M. 2012). 
 
Common functional disorder symptoms in-
clude limb weaknesses, dissociative attacks 
and chronic pain. It is estimated that between 
2 to 33 per 100,000 people suffer dissociative 
attacks and 90 people per 100,000 suffer 
from functional weakness (Stone et al, 2009). 
Functional weakness interestingly has a simi-
lar prevalence to multiple sclerosis. Function-
al symptoms can be difficult to diagnose due 
to the nature of the symptoms as well as pa-
tient background and history. This presents 
many problems for health practitioners in the 
diagnosis, treatment and rehabilitation phas-
es of care. 
 
The cost of medically unexplained symptoms 
(MUS) is estimated to cost the NHS in Eng-
land £18 billion per year (NHS 2015). An Au-
dit by the NHS estimate FND patient’s aver-
age 5 ward admission, 6 accidents and emer-
gency admissions and 24 days length of stay 
in hospitals between 2009-2012 (Adjei, M. 
Coebergh, J. A. 2014). 
 
This presentation aims to raise awareness of 
FND by providing an insight into the diagno-
sis, treatment and rehabilitation of the disor-
der. The presentation will discuss nursing 
strategies used to help treat and progress 
patients through therapy and explore the stig-
ma surrounding FND and how it can be re-
duced to deliver effective treatments and pro-
vide the patients with evidence based care to 
ensure better outcomes and reduce hospital 
length of stays. There will be two case 
presentations at the end discussing poor and 
successful outcomes.  
 
 
Low-fat versus ketogenic diet in Parkin-
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son’s disease: a pilot randomised con-
trolled trial 
 
MCL Phillips, DKJ Murtagh, LJ Gilbertson, 
FJS Asztely. 
Waikato Hospital, New Zealand 
DOI: 10.21307/ajon-2017-012l 
Background: Preliminary evidence suggests 
that dietary manipulation may influence motor 
and non-motor symptoms in PD, but conflict 
exists regarding the ideal fat to carbohydrate 
ratio.  
 
Objectives: We designed a pilot randomized 
controlled trial to compare the plausibility, 
safety, and efficacy of a low-fat, high-
carbohydrate diet versus a ketogenic diet in a 
hospital clinic of PD patients. 
 
Methods: We developed a protocol to support 
PD patients in a diet study and randomly as-
signed patients to a low-fat or ketogenic diet. 
Primary outcomes were within- and between-
group changes in MDS-UPDRS Parts 1-4 
over eight weeks. 
 
Results: We randomized 47 patients, of 
which 44 commenced the diets and 38 com-
pleted the study (86% completion rate for 
patients commencing the diets). The keto-
genic group maintained physiological ketosis. 
Both groups significantly decreased their 
MDS-UPDRS scores, but the ketogenic 
group decreased more in Part 1 (low-fat 
group: -0.99 +/- 3.63 points vs ketogenic 
group: -4.58 +/- 2.17 points, P<0.001), with 
the largest between-group decreases ob-
served for urinary problems, pain and other 
sensations, fatigue, daytime sleepiness, and 
cognitive impairment; there were no between
-group differences in the magnitude of de-
crease for Parts 2-4. The most common ad-
verse effects were excessive hunger in the 
low-fat group and intermittent exacerbation of 
the PD tremor and/or rigidity in the ketogenic 
group. 
 
Conclusions: t is plausible and safe for PD 
patients to maintain a low-fat or ketogenic 
diet for eight weeks. Both diet groups signifi-
cantly improved in motor and non-motor 
symptoms, however the ketogenic group 
showed greater improvements in non-motor 
symptoms.  
 
 
Managing migraines with a nurse 
 
Sharon Bale 
Migraine Specialists, Brisbane, Queensland, 
Australia 
DOI: 10.21307/ajon-2017-012m 
 
Managing migraines with a nurse gives the 
patient an opportunity to sit down with a clini-
cian to take the time to discuss the signs and 
symptoms of their condition. This allows the 
Multidisciplinary team to have a clearer diag-
nosis of the type of the patient’s headaches 
and migraines.  
 
The patient who has Migraines is often left 
feeling like nobody understands their condi-
tion; the nurse who will empathetically guide 
the patient through their migraine journey can 
have an enormous impact on the patient’s 
life. In the past migraine has often been dis-
regarded by the general population and even 
medical professionals at time with stigmas 
attached to their condition.  
 
Nurses can play a significant role in migraine 
management by offering the patient ongoing 
support, empathy and advice. Many patients 
benefit from information about over the coun-
ter medications, prescription medications, 
management of their triggers and the adjust-
ment of their lifestyles and early effective 
treatment to assist with their management of 
migraines.  
 
During this discussion we will cover the role 
of the Headache specialist nurse in a clinical 
role working alongside a multidisciplinary 
team in a private setting.  
 
 
Collaborative multidisciplinary approach 
to improve door to needle time for hyper 
acute stroke treatment 
 
Adrienne Ling, Sheila Jala,  Heather Thom 
Royal North Shore Hospital, Sydney, New 
South Wales, Australia 
DOI: 10.21307/ajon-2017-012n 
 
Thrombolysis and endovascular treatment for 
patients with ischaemic stroke is a time criti-
cal therapy. Delay in treatment increases 
mortality, worsens disability and reduces effi-
cacy of treatment.  
 
This quality improvement project was con-
ducted at a tertiary referral facility in Sydney. 
Collaboration with health professionals from 
all disciplines (e.g. Emergency, Neurology, 
Neurointerventional radiology and Intensive 
Care) where included to outline roles for 
team members and implementing an emer-
gency stroke call out system.  
 
Prospective data was collected before imple-
mentation (July 2014-March 2016) and after 
implementation (April 2016-December 2017).  
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To co-ordinate and achieve early notification 
of multidisciplinary team for stroke thrombo-
lysis to improve thrombolysis rates and door 
to needle time. A Neurointerventional radiolo-
gy (INR) CNC was appointed for a 6 month 
period to examine work processes and pa-
tient’s safety and care journey.  
 
Processes:   
1) Pre-hospital identification of patient requir-
ing transfer and treatment in a tertiary hospi-
tal. 
2) Examining triage processes and require-
ments of care from an ED perspective. 
3) Co-ordination of teams attending “Stroke 
page’ and their responsibility. 
4) Patients clinical treatment destination loca-
tion. 
 
Descriptive statistics were performed; medi-
ans (IQR) for continuous data and fre-
quencies/percentages for categorical data. 
Differences for continuous data were ex-
plored using the Mann-Whitney U-test and 
categorical data were explored using the 
Pearson’s chi-square test.  
 
There were no group differences in patient 
characteristics; the sample was predominant-
ly male with mild to moderate stroke severity 
and median age 78 years. There was a trend 
to an increased thrombolysis rate but this 
was not statistically different; before 152 of 
589 (25.8%) vs after 209 of 725 (28.8%) pa-
tients received thrombolysis (P=0.22). The 
difference in median time to treatment was 
significant; 65.5 (45.0-84.0) vs 47.0 (30.3-
65.0) min, P<0.001, respectively.  
 
Implementation of committed multidisciplinary 
stroke team using an emergency stroke call 
out system resulted in a trend to improved 
thrombolysis rate and time to treatment. 
 
 
Impact on patients with Obstructive Sleep 
Apnoea (OSA) of spinal precautions: is it 
time to change practice? 
 
Sharryn Byers, Elizabeth Whale, Lerma 
Cruz 
Nepean Hospital, Sydney, New South Wales, 
Australia 
DOI: 10.21307/ajon-2017-012o 
 
Obstructive Sleep Apnoea (OSA) occurs in 
approximately 5% of the population. In the 
surgical population the impact of undiag-
nosed OSA is gaining a greater understand-
ing although the impact on patient outcomes 
in the neurosurgical population has not been 
investigated. 
 
This case study will outline the journey of a 
patient for whom the combination of undiag-
nosed OSA and a C1# proved fatal. 
The learnings from both a literature review on 
spinal precautions and the case review pro-
cess will be shared. 
 
The intended outcome is to increase 
knowledge and awareness of the impact of 
OSA along with the need to alter our care for 
this at risk population. The evidence for how 
we alter our care, however, is not currently 
available.  
 
 
Malignant middle cerebral artery infarct: 
an integrated clinical case presentation 
and literature review 
 
Kwanyee Leung, Shelia Jala, Rosalind El-
liot 
Manly and Mona Vale Hospitals, Sydney, 
New South Wales, Australia 
DOI: 10.21307/ajon-2017-012p 
 
Ischaemic stroke accounts for 87% of all 
strokes. It occurs when a clot or a thrombus 
blocks a blood vessel, cutting off blood flow 
to a part of the brain. If large proportions of a 
hemisphere are affected, space-occupying 
oedema may result leading to rapid neurolog-
ical deterioration, irreversible coma and 
death. Malignant middle cerebral artery in-
farction (MMCAI) is a life-threating form of 
ischaemic stroke involving the whole middle 
cerebral artery (MCA) territory and comprises 
up to 10% of all MCA territory infarctions.  
Mary was a 62 year old women found col-
lapsed at home by her daughter who after 
unsuccessful treatment with ECR later under-
went surgical decompression. Mary made a 
good functional recovery returning home to 
live independently. This case highlights the 
vital role the stroke nurse specialist and criti-
cal care nurse play in the assessment and 
treatment of this typical patient who experi-
enced a MMCAI and underwent complex in-
terventions.  
 
 
Treatment with intravenous tissue plas-
minogen activator for acute ischaemic 
stroke after reversal of Dabigatran and 
Idarucizumab: a 
case study 
 
Sheila Jala, Elizabeth O’Brien 
Royal North Shore Hospital, Sydney, New 
South Wales, Australia 
DOI: 10.21307/ajon-2017-012q 
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Treatment options for anticoagulated patients 
presenting with ischaemic stroke are limited. 
Off-label use of idarucizumab to rapidly re-
verse the anticoagulant effect of dabigatran 
may ensure eligibility for thrombolytic therapy 
with recombinant tissue plasminogen activa-
tor (rtPA). This case describes a 77 year-old 
previously independent man of Anglo-Saxon 
origin who presented to hospital 89 minutes 
following sudden onset of right sided hemi-
paresis, dysarthria and facial palsy. Signifi-
cant history included Atrial Fibrillation (AF) 
and previous right-sided cortical stroke. Medi-
cation reconciliation revealed he was taking 
dabigatran 150 mg twice a day, the last dose 
– 179 minutes prior to presentation.  
 
An urgent non-contrast computed tomogra-
phy (CT) scan showed no new infarct or 
haemorrhage. 60 minutes from hospital arri-
val a decision was made to give idaruci-
zumab to reverse the anticoagulant effect of 
dabigatran, in the absence of any contraindi-
cation, the patient was successfully treated 
with intravenous (IV) rtPA. Both rtPA and ida-
rucizumab were tolerated with no adverse 
outcomes.  
 
At discharge, the patient’s new stroke symp-
toms were completely resolved. In this case, 
the reversal of dabigatran using idaruci-
zumab was safe and successful with no rtPA 
adverse events. Clinicians should consider 
dabigatran reversal for those who are other-
wise eligible for thrombolysis. Further report-
ing of patients who receive this therapy will 
be of use in the absence of trial evidence. 
Additionally, the role of the stroke nurse was 
vital in ensuring that team members were 
working together towards providing quality 
hyperacute stroke care for this patient.  
 
 
Australia’s first patient with Huntington’s 
Disease treated with Deep Brain Stimula-
tion surgery 
 
Emma Everingham 
Westmead Hospital, Sydney, New South 
Wales, Australia 
DOI: 10.21307/ajon-2017-012r 
 
Objectives: 1. Outline the patient’s progress 
during the first 12 months following deep 
brain stimulation (DBS) surgery to treat cho-
rea secondary to Huntington’s disease. 
2. Describe the role of the Movement Disor-
der Nurse Practitioner. 
 
Materials/Methods: Baseline clinical presen-
tation, the screening process for surgical suit-
ability and pre-operative assessments will be 
overviewed. The surgical technique for inser-
tion of bilateral globus pallidus interna (GPi) 
electrodes will be described, highlighting the 
difficulties due to atrophy of the target struc-
ture. Multi-disciplinary team reviews during 
the first twelve months, including stimulation 
parameter adjustments, will be explained. 
The reduction in chorea movements will be 
demonstrated through progressive video as-
sessments. 
 
Results: Four months after DBS the general-
ised chorea movements reduced by 56%. 
There was a positive impact on the patient 
and carers quality of life. Stimulation induced 
side effects, including bradykinesia and other 
potential complications of DBS, will be pre-
sented. 
 
Conclusions: There was a reduction in cho-
rea movements and a marked positive impact 
on quality of life following GPi DBS surgery in 
a carefully screened person with Huntington’s 
Disease.  
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Long term evaluation of clinical and radio-
logical outcomes after anterior cervical 
discectomy and fusion, using a porous 
titanium cage and an anterior plate (work-
in-progress) 
 
Kaileen Lynch, Dr Peter Lucas, Scott Dry-
burgh, Jasmine Roberts 
Brisbane Private Hospital, Queensland, Aus-
tralia 
DOI: 10.21307/ajon-2017-012s 
 
Anterior cervical discectomy and fusion 
(ACDF) has been used since the 1950’s to 
relieve symptoms associated with cervical 
disc diseases. Developments to reduce com-
plications have included the use of interverte-
bral cages and the optional use of anterior 
cervical plates. Titanium, PEEK, and carbon 
fiber are the materials leading the technical 
advances in cage design.  
 
Recently, porous titanium has shown favour-
able osteoconduction properties, with prelimi-
nary results from cervical cages (EITGmbH) 
reporting fusion in 80% of ACDF patients at 
12 months. Despite these developments, no 
single cage/plate combination is considered 
the gold standard. This study aims to provide 
information on the long term use of porous 
titanium cervical cages used in combination 
with a plate, by reporting on the clinical and 
radiological outcomes of ACDF patients over 
5 years. 
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 A prospective cohort study of 50 1-2 level 
ACDF patients with a 5 year follow up period, 
commenced in 2017. The study will evaluate 
the clinical and radiological outcomes of 
ACDF surgery, with post-operative follow-ups 
at 6 weeks, 3, 6 and 9 months, then annually 
for 5 years. Clinical measurements include 
the assessment of pain (VAS), disability 
(NDI), general health (SF36), and surgical 
data. X-rays at each follow-up and a 12 
month CT scan will be used for radiological 
assessments including the evaluation of fu-
sion, cage subsidence/complication, global 
cervical angle, and Adjacent Segments Dis-
ease. 
 
Porous titanium cages have shown promising 
initial results in ACDF patients. This study will 
enable further evaluation of these cages by 
providing comprehensive long term results on 
the clinical/radiological outcomes of ACDF 
patients. Additionally, analysis of this cohort 
to historical controls that have used alterna-
tive cage/plate combinations will contribute 
towards the development of a gold standard 
ACDF technique  
 
 
The creation and evolution of a nurse led 
first seizure clinic 
 
Linda Gilbertson 
Waikato Hospital, New Zealand 
DOI: 10.21307/ajon-2017-012t 
 
The creation and evolution of a nurse led first 
seizure clinic. Up to 10% (Angus-Leppan, 
2014, pp. 27-31) of the population will have a 
seizure during their lives.  Between 35 and 
70% (Angus-Leppan, 2014) of those will have 
further seizures.  In a pilot study done at Wai-
kato hospital, 41% of those presenting to a 
new, nurse led, first seizure clinic (NLFSC) 
were thought to have had an event clearly 
identified as a seizure. 
 
The pilot study was set up with the aim of 
creating a permanent NLFSC. It was felt that 
this clinic would allow patients to be seen 
more timeously, triaged, investigated and 
then followed up where appropriate. A first 
seizure questionnaire was developed, in con-
sultation with specialist neurologists. Data 
from the questionnaire was captured into a 
database for analysis 
 
Two groups were identified as potential refer-
rers to the clinic, GPs and the emergency 
department. Education sessions were held 
and a new referral form was developed and 
distributed. Questionnaires were completed 
by a nurse and discussed with a neurologist. 
Most patients had an EEG at the time of the 
consultation. Where possible, the EEG was 
reported by the neurologist supervising the 
clinic and all patients were discussed with the 
neurologist. During that discussion a working 
diagnosis was put forward, follow up was 
planned, further investigations initiated and 
the critical issue of driving discussed. When 
200 patients had been seen an audit was 
conducted. A decision was made to continue 
the clinics in a slightly modified manner using 
a lightly modified questionnaire. 
 
This presentation is not about analysis of the 
data which will be published elsewhere. It is 
about the evolution and effectiveness of a 
nurse led clinic for this group of patients. 
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